Robbie Marcus
Stock Analyst at JP Morgan
(3.97)
# 560
Out of 5,182 analysts
181
Total ratings
57.14%
Success rate
8.89%
Average return
Main Sectors:
Stocks Rated by Robbie Marcus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HTFL HeartFlow | Maintains: Overweight | $40 → $35 | $31.73 | +10.31% | 3 | Mar 19, 2026 | |
| PODD Insulet | Maintains: Overweight | $415 → $340 | $188.31 | +80.55% | 5 | Feb 19, 2026 | |
| MDT Medtronic | Maintains: Neutral | $105 → $100 | $82.92 | +20.60% | 13 | Feb 18, 2026 | |
| BSX Boston Scientific | Maintains: Overweight | $135 → $100 | $59.95 | +66.81% | 14 | Feb 5, 2026 | |
| EW Edwards Lifesciences | Upgrades: Overweight | $90 → $100 | $83.46 | +19.82% | 7 | Dec 18, 2025 | |
| INSP Inspire Medical Systems | Maintains: Neutral | $82 → $118 | $55.07 | +114.27% | 8 | Dec 16, 2025 | |
| COO The Cooper Companies | Maintains: Neutral | $66 → $78 | $64.34 | +21.23% | 7 | Dec 5, 2025 | |
| CNMD CONMED | Maintains: Neutral | $58 → $52 | $37.87 | +37.31% | 8 | Nov 6, 2025 | |
| RXST RxSight | Maintains: Underweight | $8 → $9 | $7.29 | +23.46% | 6 | Nov 6, 2025 | |
| ZBH Zimmer Biomet Holdings | Downgrades: Neutral | $115 → $100 | $92.59 | +8.00% | 7 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $21 → $17 | $21.14 | -19.58% | 2 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $75 | $61.41 | +22.13% | 3 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $12 → $13 | $10.69 | +21.61% | 7 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $16 | $15.88 | +0.76% | 3 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $16 | $17.25 | -7.25% | 5 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $15 → $7 | $7.65 | -8.50% | 7 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $120 | $67.43 | +77.96% | 1 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $36 | $18.49 | +94.70% | 17 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $445 | $329.01 | +35.25% | 9 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $575 → $675 | $470.99 | +43.32% | 5 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $12 → $13 | $10.01 | +29.87% | 3 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $40 | $29.04 | +37.74% | 5 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $90 | $70.48 | +27.70% | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $53 → $50 | $24.54 | +103.75% | 2 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $8 | $1.92 | +316.67% | 2 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $284 → $250 | $327.98 | -23.78% | 9 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $8 → $7 | $7.25 | -3.45% | 13 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $125 → $118 | $92.80 | +27.16% | 5 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $116 → $156 | $125.96 | +23.85% | 2 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $40 | $122.07 | -67.23% | 2 | May 5, 2020 |
HeartFlow
Mar 19, 2026
Maintains: Overweight
Price Target: $40 → $35
Current: $31.73
Upside: +10.31%
Insulet
Feb 19, 2026
Maintains: Overweight
Price Target: $415 → $340
Current: $188.31
Upside: +80.55%
Medtronic
Feb 18, 2026
Maintains: Neutral
Price Target: $105 → $100
Current: $82.92
Upside: +20.60%
Boston Scientific
Feb 5, 2026
Maintains: Overweight
Price Target: $135 → $100
Current: $59.95
Upside: +66.81%
Edwards Lifesciences
Dec 18, 2025
Upgrades: Overweight
Price Target: $90 → $100
Current: $83.46
Upside: +19.82%
Inspire Medical Systems
Dec 16, 2025
Maintains: Neutral
Price Target: $82 → $118
Current: $55.07
Upside: +114.27%
The Cooper Companies
Dec 5, 2025
Maintains: Neutral
Price Target: $66 → $78
Current: $64.34
Upside: +21.23%
CONMED
Nov 6, 2025
Maintains: Neutral
Price Target: $58 → $52
Current: $37.87
Upside: +37.31%
RxSight
Nov 6, 2025
Maintains: Underweight
Price Target: $8 → $9
Current: $7.29
Upside: +23.46%
Zimmer Biomet Holdings
Nov 6, 2025
Downgrades: Neutral
Price Target: $115 → $100
Current: $92.59
Upside: +8.00%
Nov 5, 2025
Maintains: Overweight
Price Target: $21 → $17
Current: $21.14
Upside: -19.58%
Oct 31, 2025
Maintains: Neutral
Price Target: $90 → $75
Current: $61.41
Upside: +22.13%
Oct 31, 2025
Maintains: Underweight
Price Target: $12 → $13
Current: $10.69
Upside: +21.61%
Oct 30, 2025
Maintains: Neutral
Price Target: $13 → $16
Current: $15.88
Upside: +0.76%
May 14, 2025
Maintains: Overweight
Price Target: $14 → $16
Current: $17.25
Upside: -7.25%
May 9, 2025
Downgrades: Underweight
Price Target: $15 → $7
Current: $7.65
Upside: -8.50%
Mar 28, 2025
Initiates: Overweight
Price Target: $120
Current: $67.43
Upside: +77.96%
Feb 21, 2025
Maintains: Neutral
Price Target: $38 → $36
Current: $18.49
Upside: +94.70%
Jan 29, 2025
Maintains: Overweight
Price Target: $420 → $445
Current: $329.01
Upside: +35.25%
Jan 24, 2025
Maintains: Overweight
Price Target: $575 → $675
Current: $470.99
Upside: +43.32%
Dec 17, 2024
Upgrades: Neutral
Price Target: $12 → $13
Current: $10.01
Upside: +29.87%
Oct 30, 2024
Maintains: Overweight
Price Target: $30 → $40
Current: $29.04
Upside: +37.74%
Sep 9, 2024
Initiates: Neutral
Price Target: $90
Current: $70.48
Upside: +27.70%
Aug 8, 2024
Maintains: Neutral
Price Target: $53 → $50
Current: $24.54
Upside: +103.75%
May 8, 2024
Downgrades: Neutral
Price Target: $15 → $8
Current: $1.92
Upside: +316.67%
Feb 23, 2024
Downgrades: Neutral
Price Target: $284 → $250
Current: $327.98
Upside: -23.78%
Nov 8, 2023
Maintains: Underweight
Price Target: $8 → $7
Current: $7.25
Upside: -3.45%
Oct 20, 2022
Maintains: Overweight
Price Target: $125 → $118
Current: $92.80
Upside: +27.16%
Jan 27, 2022
Maintains: Overweight
Price Target: $116 → $156
Current: $125.96
Upside: +23.85%
May 5, 2020
Maintains: Neutral
Price Target: $55 → $40
Current: $122.07
Upside: -67.23%